EURO STOXX Technology
1.101,60
PKT
-20,70
PKT
-1,84
%
Werbung
Analysen zu EURO STOXX Technology-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.03.05 | SAP Strong Buy | SEB | |
18.03.05 | SAP Outperform | HypoVereinsbank | |
17.03.05 | SAP Outperform | RBC Capital Markets | |
17.03.05 | Siemens Overweight | JP Morgan | |
18.03.05 | Siemens Outperform | HypoVereinsbank | |
16.03.05 | Siemens Outperform | HypoVereinsbank | |
15.03.05 | Siemens Outperform | HypoVereinsbank | |
14.03.05 | SAP Overweight | JP Morgan | |
14.03.05 | Siemens Outperform | HypoVereinsbank | |
14.03.05 | SAP Outperform | HypoVereinsbank | |
16.03.05 | Siemens Buy | Merck Finck & Co | |
14.03.05 | SAP Overweight | JP Morgan | |
10.03.05 | Siemens Outperform | HypoVereinsbank | |
09.03.05 | SAP Buy | Merrill Lynch | |
10.03.05 | SAP Outperformer | LB Rheinland-Pfalz | |
10.03.05 | SAP Overweight | JP Morgan | |
10.03.05 | SAP Akkumulieren | Independent Research | |
11.03.05 | SAP Outperform | HypoVereinsbank | |
09.03.05 | Siemens Buy | Dresdner Kleinwort Wasserstein | |
09.03.05 | SAP Outperform | HypoVereinsbank | |
09.03.05 | Siemens Outperform | HypoVereinsbank | |
10.03.05 | Siemens Neutral | Sal. Oppenheim | |
09.03.05 | Siemens Outperform | HypoVereinsbank | |
07.03.05 | SAP Akkumulieren | Independent Research | |
08.03.05 | SAP Strong Buy | SEB | |
04.03.05 | Siemens Buy | Merck Finck & Co | |
04.03.05 | Siemens Outperformer | LB Baden-Württemberg | |
04.03.05 | Siemens Outperform | HypoVereinsbank | |
04.03.05 | Siemens Halten | Helaba Trust | |
03.03.05 | Siemens Buy | Merck Finck & Co | |
03.03.05 | Siemens Outperform | HypoVereinsbank | |
01.03.05 | SAP Outperform | HypoVereinsbank | |
01.03.05 | SAP Hold | Merck Finck & Co | |
01.03.05 | SAP Akkumulieren | Independent Research | |
01.03.05 | SAP Overweight | JP Morgan | |
01.03.05 | SAP Outperform | Goldman Sachs | |
01.03.05 | SAP Outperformer | LB Rheinland-Pfalz | |
02.03.05 | SAP Strong Buy | SEB | |
01.03.05 | SAP Marketperformer | SES Research | |
25.02.05 | Siemens Buy | Merck Finck & Co |